TOP GUIDELINES OF GR 113808

quinupristin/dalfopristin will increase the level or result of lemborexant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Stay away from coadministration of lemborexant with reasonable or solid CYP3A inhibitors.quinupristin/dalfopristin will enhance the degree or outcome of lumateperone by affectin